You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Accommodation integrated technology to minimize the impact of disability on students' assessment

    SBC: 3-C Institute for Social Development, Inc.            Topic: N/A

    There is growing interest in computerized systems to increase accessibility of assessments for students with disabilities. Technology offers an ideal platform for implementing Universal Design (UD) principles for assessment to better accommodate student diversity and support broad student participation. The goal of this Phase II SBIR project is to continue the research and development of Assess2Pr ...

    SBIR Phase II 2014 Department of Education
  2. The Intelligent Brace: A Compliance Monitoring System for Scoliosis

    SBC: LIBERATING TECHNOLOGIES INC            Topic: N/A

    Scoliosis, a condition where there is lateral curvature of the spine, affects an estimated 6 million people in the United States. There is widespread use of bracing for treatment of adolescent idiopathic scoliosis, and recent studies have begun documenting its efficacy. These studies have indicated that user compliance is a large, yet largely unquantified, factor in successful outcomes. There are ...

    SBIR Phase II 2014 Department of Education
  3. Developing Intravesical Liposomes for Interstitial Cystitis

    SBC: Lipella Pharmaceuticals Inc.            Topic: NIDDK

    DESCRIPTION (provided by applicant): Lipella Pharmaceuticals Inc. (Pittsburgh, PA) is a clinical-stage pharmaceutical company specializing in intravesical therapies for urinary bladder dysfunctions. Lipella is submitting a research proposal to the Small Business Technology Transfer program titled Developing Intravesical Liposomes for Interstitial Cystitis . The project proposes to evaluate the sa ...

    STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  4. CONTRACT # N44CO-2014-00003C P.O.P. 5/15/2014-5/14/2015; IND ENABLING DEVELOPMENT OF NANOGMP: TARGETED; PURPOSE: TO PROVIDE FY14 FUNDING FOR SBIR PHASE II AWARD

    SBC: QUALIBER, INC.            Topic: NCI

    Not Available

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  5. IGF::OT::IGF SBIR Topic 314 Phase II- 3D Human Tumor Co-culture System for Accurate Prediction of Clinical Efficacy.

    SBC: KIYATEC, LLC            Topic: NCI

    Not Available

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  6. Arise: An Online Relapse Prevention Tool for Substance Abusers

    SBC: 3-C Institute for Social Development, Inc.            Topic: NIDA

    Modify Phase I product and develop the full Arise product. Modify initial prototype based on feedback and fully develop all six modules. PUBLIC HEALTH RELEVANCE

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  7. IGF::OT::IGF SBIR Phase II Topic 62, Strategy for Finding Cases of Moderate-to-Severe COPD

    SBC: DIMAGI, INC.            Topic: DLD

    Not Available

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  8. IGF::OT::IGF SBIR Topic 58, Phase II- High-Voltage Li-ion Battery for Left Ventricular Assist Device Power

    SBC: GINER INC            Topic: NHLBI

    Not Available

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  9. Development of Praedicare Dx as CDx for AML Period of Performance: September 19, 2014 through September 18, 2015

    SBC: Eutropics Pharmaceuticals, Inc.            Topic: DCCPS

    Not Available

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  10. Advancing a Mucosal HSV-2 Vaccine Towards Clinical Trials

    SBC: Biomedical Research Models, Inc.            Topic: NIAID

    DESCRIPTION (provided by applicant): Globally, an estimated 16.2% of the human population is infected with HSV-2 including gt17% of the U.S. adult population. Genital herpes is associated with an increased risk of HIV acquisition and transmission and HSV-2infection can cause neonatal herpes with high infant mortality. HSV-2 infection in the adult population has increased substantially in the past ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government